Recently,
Teleflex Incorporated
(
TFX
), a global leader in medical devices used in critical care and
surgery, launched its latest online catalog for Hudson RCI
Respiratory products. The intuitive catalog is available on the
company website.
Through its Teleflex Medical division, the company develops and
provides various brands of products such as Hudson RCI, Rusch and
Arrow among others. Teleflex is marketing its respiratory and
anesthesia products under the Hudson RCI brand since July,
2004.
The Hudson RCI brand provides a wide portfolio which includes
oxygen therapy products, aerosol therapy products, passive
humidification and filtration products, active humidification and
breathing circuits, resuscitation bags, incentive spirometers and
adaptors and connectors. The online catalog encompassing these
products is compatible with traditional desktops as well as other
high-end smartphones, gadgets and tablets including
Apple Inc.
's (
AAPL
) iPad.
According to Teleflex, the online catalog will provide a
convenient, 24 hour access to the consumers. It is also expected to
build customer relationships as the web provides an interactive
medium to the company.
Not only the online catalogs are more flexible and inexpensive,
they also offer a wider access to customers as the internet
connects millions of global citizens. It will also allow Teleflex
to easily and frequently update product and price information for
prospective customers.
Aided by this online marketing initiative, Limerick,
Pennsylvania-based Teleflex might be able to gain an edge over its
competitors and bolster its top line. The company's strategy to
develop new, innovative products along with the divestiture of its
OEM Orthopedic division should help improve its financial
performance in the long run. The company's focus on profitable and
consistent growth along with the introduction of new products as
well as portfolio expansion via acquisitions is expected to yield
results.
However,
Covidien
(
COV
),
C.R. Bard
(
BCR
) and
CareFusion
(
CFN
), which operate in similar business segments, present a tough
competitive landscape for Teleflex. Additionally, the company
operates in a stringent regulatory environment. The demand for its
products is susceptible to healthcare reimbursement systems in the
domestic as well as the international market.
Teleflex currently retains a Zacks #3 Rank, which translates
into a short-term Hold rating.
APPLE INC (AAPL): Free Stock Analysis Report
BARD C R INC (BCR): Free Stock Analysis Report
CAREFUSION CORP (CFN): Free Stock Analysis
Report
COVIDIEN PLC (COV): Free Stock Analysis Report
TELEFLEX INC (TFX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment
Research